High Lymph Node Yield is Related to Microsatellite Instability in Colon Cancer

[1] Gill S(2004)Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 22 1797-1806

[2] Loprinzi CL(2004)Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med. 350 2343-2351

[3] Sargent DJ(1999)Comparative efficacy of adjuvant chemotherapy in patients with Dukes’ B versus Dukes’ C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) J Clin Oncol. 17 1349-1355

[4] Thomé SD(1996)Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered Am J Clin Pathol. 106 209-216

[5] Alberts SR(1994)Colorectal adenocarcinoma: quality of the assessment of lymph node metastases Dis Colon Rectum. 37 373-376

[6] Haller DG(2003)The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined Ann Surg Oncol. 10 65-71

[7] Andre T(2009)Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer Int J Colorectal Dis. 24 283-288

[8] Boni C(1999)Number of nodes examined and staging accuracy in colorectal carcinoma J Clin Oncol. 17 2896-2900

[9] Mounedji-Boudiaf L(1998)For patients with Dukes’ B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis Cancer. 83 666-672

[10] Navarro M(2006)More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study Ann Surg. 244 602-610

[1] Gill S(2004)Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 22 1797-1806

[2] Loprinzi CL(2004)Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med. 350 2343-2351

[3] Sargent DJ(1999)Comparative efficacy of adjuvant chemotherapy in patients with Dukes’ B versus Dukes’ C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) J Clin Oncol. 17 1349-1355

[4] Thomé SD(1996)Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered Am J Clin Pathol. 106 209-216

[5] Alberts SR(1994)Colorectal adenocarcinoma: quality of the assessment of lymph node metastases Dis Colon Rectum. 37 373-376

[6] Haller DG(2003)The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined Ann Surg Oncol. 10 65-71

[7] Andre T(2009)Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer Int J Colorectal Dis. 24 283-288

[8] Boni C(1999)Number of nodes examined and staging accuracy in colorectal carcinoma J Clin Oncol. 17 2896-2900

[9] Mounedji-Boudiaf L(1998)For patients with Dukes’ B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis Cancer. 83 666-672

[10] Navarro M(2006)More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study Ann Surg. 244 602-610